Prospectus, May 2, 1978

POSSIBLE CHANUTE CLOSING \u27SHOCKS\u27 CITIZENS; Student elections are today and tomorrow; Letters to the editors: Religion and science again, \u27Stu-go not a total farce\u27; Spring bike riders should watch wheels; \u27Tricky little devils\u27 read poetry at PC; Parkland College News in brief: Law Enforcement Club will sponsor fair, Mrs. Staerkel hosts installation, Avoid math workshop begins, Breakfast is served, PC choir gives concert, U of I alumnus gets Pulitzer, Renew locker space now; Bottle bill fights for clean land, less cost; Neal Robinson receives award; Warning! Poison pot found in C-U area; Parkland women journalist reflects on \u27tradition\u27; Farmland plots for rent; Classifieds; Stu-go hopefuls run for top jobs, ask your vote; Commencement plans announced for May 25; Smithson to join Parkland team; Cobras win second 5-4; Williams to be new Parkland wrestling coachhttps://spark.parkland.edu/prospectus_1978/1015/thumbnail.jp

Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients The ENDORSE Global Survey

Limited data are available regarding the risk for venous thromboembolism (VIE) and VIE prophylaxis use in hospitalised medically ill patients. We analysed data from the global ENDORSE survey to evaluate VTE risk and prophylaxis use in this population according to diagnosis, baseline characteristics, and country. Data on patient characteristics, VIE risk, and prophylaxis use were abstracted from hospital charts. VTE risk and prophylaxis use were evaluated according to the 2004 American College of Chest Physicians (ACCP) guidelines. Multivariable analysis was performed to identify factors associated with use of ACCP-recommended prophylaxis. Data were evaluated for 37,356 hospitalised medical patients across 32 countries. VIE risk varied according to medical diagnosis, from 31.2% of patients with gastrointestinal/hepatobiliary diseases to 100% of patients with acute heart failure, active noninfectious respiratory disease, or pulmonary infection (global rate, 41.5%). Among those at risk for VTE, ACCP-recommended prophylaxis was used in 24.4% haemorrhagic stroke patients and 40-45% of cardiopulmonary disease patients (global rate, 39.5%). Large differences in prophylaxis use were observed among countries. Markers of disease severity, including central venous catheters, mechanical ventilation, and admission to intensive care units, were strongly associated with use of ACCP-recommended prophylaxis. In conclusion, VIE risk varies according to medical diagnosis. Less than 40% of at-risk hospitalised medical patients receive ACCP-recommended prophylaxis. Prophylaxis use appears to be associated with disease severity rather than medical diagnosis. These data support the necessity to improve implementation of available guidelines for evaluating VIE risk and providing prophylaxis to hospitalised medical patients

Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey) Findings in Surgical Patients

Objective: To evaluate venous thromboembolism (VTE) risk in patients who underwent a major operation, including the use of, and factors influencing, American College of Chest Physicians-recommended types of VTE prophylaxis